Responsibilities:
- Maintain and update employee records, ensuring the accuracy and confidentiality of all data.
- New hire onboarding and orientation, including coordination of paperwork, scheduling, and delivery of orientation content.
- Maintain accurate and timely employee data by processing and documenting personnel actions such as new hires, promotions, transfers, job changes, and terminations.
- Administer employee benefits programs, ensuring accurate and timely enrollment, updates, and communication.
- Ensure compliance with federal, state, and local employment laws and regulations, staying current with updates and changes.
- Serve as the primary day-to-day point of contact for employees regarding HR-related questions.
- Apply working knowledge of employment laws and regulations, including FMLA, ADA, leaves of absence, and NLRA; escalate and partner with Legal or HR leadership as needed.
- Ensure data integrity across HR systems to support payroll, benefits administration, compliance, and reporting requirements.
- Support audits and ensure compliance with internal policies and external regulatory requirements.
- Some recruitment support, including job postings, candidate screening, interviewing on as needed basis.
- Conduct regular audits of HR processes and systems to identify areas for improvement and optimization.
- Support performance management processes, recognition programs, training initiatives, and company-wide HR events.
- Provide guidance and support on employee relations issues, including conflict resolution, disciplinary actions, and performance management.
- Handle confidential and sensitive employee information with professionalism, discretion, and strict adherence to company privacy and confidentiality standards.
- Work closely with managers and employees to strengthen working relationships, enhance engagement, and support employee retention initiatives.
Required Skills & Qualifications:
- 3-5 years of progressive HR experience preferably in Biotech.
- Must be willing to be onsite 5 days a week.
- In-depth knowledge of HR best practices, employment laws, and regulations.
- Strong organizational skills with attention to detail and accuracy.
- Working knowledge of benefits administration.
- Excellent verbal and written communication skills with strong organizational, documentation, and follow-up abilities.
- High level of discretion and professionalism when handling confidential and sensitive employee matters.
- Proficiency in Microsoft Office applications (Outlook, Word, Excel) and HRIS platforms.
- Ability to manage multiple priorities, meet deadlines, and adapt to changing business needs.
- Self-motivated, proactive, and collaborative team player.
The base pay range for this position at commencement of employment is expected to be between $110K and $135K / year; however, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. The Company's proprietary peptide technology platform enables
de novo discovery of peptide therapeutics. Two novel peptides derived from Protagonist's proprietary discovery platform are at or near commercialization. ICOTYDE™ (icotrokinra) is approved in the U.S. for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy. ICOTYDE is the first and only targeted oral peptide that precisely blocks the Interleukin-23 receptor (IL-23R) licensed to Janssen Biotech, Inc.,a Johnson & Johnson company. ICOTYDE was jointly discovered by Protagonist and Johnson & Johnson scientists, with Protagonist having primary responsibility for the development of ICOTYDE through Phase 1, and Johnson & Johnson assuming responsibility for further development and commercialization. An NDA for rusfertide, a first-in-class hepcidin mimetic peptide that is being co-developed with Takeda Pharmaceuticals pursuant to a worldwide license and collaboration agreement entered in 2024, is under priority review with the FDA. Protagonist holds an option to co-commercialize rusfertide in the U.S. through a 50/50 profit and loss share structure or can opt-out of this structure. The Company also has a number of preclinical stage drug discovery programs addressing clinically and commercially validated targets including an oral IL-17 peptide antagonist, obesity dual and triple agonists, an oral hepcidin functional mimetic, and the recently announced IL-4 and amylin programs.
More information on Protagonist, its pipeline drug candidates, and clinical studies can be found on the Company's website at https://www.protagonist-inc.com.
